We are live on ! Find out more
TECH icon

Bio-Techne

571 hedge funds and large institutions have $11.2B invested in Bio-Techne in 2024 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 213 increasing their positions, 209 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $23.6M | Put options by funds: $5.42M

49% more first-time investments, than exits

New positions opened: 67 | Existing positions closed: 45

3% more funds holding

Funds holding: 556571 (+15)

2% more repeat investments, than reductions

Existing positions increased: 213 | Existing positions reduced: 209

0% more capital invested

Capital invested by funds: $11.2B → $11.2B (+$5.87M)

1.98% less ownership

Funds ownership: 100.92%98.94% (-2%)

33% less funds holding in top 10

Funds holding in top 10: 64 (-2)

Holders
571
Holders Change
+15
Holders Change %
+2.7%
% of All Funds
8.25%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
67
Increased
213
Reduced
209
Closed
45
Calls
$23.6M
Puts
$5.42M
Net Calls
+$18.2M
Net Calls Change
+$19.6M

TECH Hedge Fund Activity: Q2 2024 in Review

571 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2024, worth a combined $11.2B — up 0.05% from $11.2B a quarter earlier.

Buyers outnumbered sellers: 67 funds opened new TECH positions and 45 closed out — a net gain of 22 holders — while 213 added to existing stakes and 209 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $205M. The largest seller was BlackRock, cutting an estimated $203M.

  • 571 institutional investors held Bio-Techne (TECH) as of Q2 2024, up from 556 in Q1 2024.
  • Funds reported $11.2B of Bio-Techne stock for Q2 2024, up 0.05% quarter-over-quarter.
  • 67 funds opened new Bio-Techne positions in Q2 2024 and 45 closed out, a net change of +22 holders.
  • The largest Bio-Techne buyer in Q2 2024 was T. Rowe Price Associates, an estimated $205M added.
  • The largest Bio-Techne seller in Q2 2024 was BlackRock, an estimated $203M sold.

Based on aggregated 13F filings for Q2 2024.